MAXHEALTH Q4 FY26 Earnings Call Transcript & Analysis
Operating EBITDA ₹682 cr (+8% YoY); Operating EBITDA Margin 26.8%; PAT ₹387 cr (+3% YoY). Network gross revenue grew 9.7% YoY to ₹2,664 crores in Q4 FY26.
Read full transcript & analysis
Every earnings call for MAXHEALTH — management tone, guidance, KPIs and promise tracking, quarter by quarter.
MAXHEALTH · 6 transcripts · Healthcare · latest Q4 FY26Operating EBITDA ₹682 cr (+8% YoY); Operating EBITDA Margin 26.8%; PAT ₹387 cr (+3% YoY). Network gross revenue grew 9.7% YoY to ₹2,664 crores in Q4 FY26.
Read full transcript & analysisOperating EBITDA ₹648 cr (+4% YoY); EBITDA Margin 26.1 percent (−4% YoY); PAT ₹344 cr (+9% YoY). 21st consecutive quarter of year-on-year growth in Q3.
Read full transcript & analysisQ4 Revenue ₹8,506 cr (+20% YoY); Full Year Revenue ₹32,554 cr (+17% YoY); Q4 EBITDA ₹2,475 cr (+32% YoY). Record high revenues exceeding $3.8 billion for full year FY25.
Read full transcript & analysis19th consecutive quarter of year-on-year growth.
Read full transcript & analysisNetwork Gross Revenue (Q4) ₹2,429 cr (+29% YoY); Network Operating EBITDA (Q4) ₹632 cr (+26% YoY); Network Operating EBITDA Margin (Q4) 27.2%. Network gross revenue grew 29% YoY to INR 2,429 crore in Q4 FY25.
Read full transcript & analysisProfit After Tax (pre-exceptional) ₹390 cr (+15% YoY). Over 30% YoY growth across revenue, EBITDA, and occupied bed days.
Read full transcript & analysis